Document Detail


Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure.
MedLine Citation:
PMID:  25273554     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
High-normal blood pressure is considered a precursor of stage 1 hypertension that is associated with metabolic disorders. This study aims to investigate whether the pharmacologic treatment of high-normal blood pressure affects metabolism, especially in abdominally obese individuals, and the pharmacoeconomics of two antihypertensive agents, telmisartan and indapamide. Subjects with high-normal blood pressure were randomly assigned to receive telmisartan, indapamide or placebo for 3 years. All the subjects were instructed to modify their lifestyle to reduce blood pressure throughout the study. A total of 221 subjects were randomly assigned to telmisartan, 213 to indapamide and 230 to placebo. After the 3-year intervention, blood pressure was lower in the telmisartan and indapamide groups (P<0.05), FPG in the telmisartan group was lower during the first 2 years (P<0.05) and no characteristic differences were found in those with abdominal obesity among the three groups (P>0.05). The percentage of subjects with metabolic syndrome was significantly decreased in the telmisartan and indapamide groups (P<0.05), but was only significantly decreased in the telmisartan group for subjects with abdominal obesity (P<0.05). The acquisition cost for telmisartan was ~1.86 times higher than for indapamide for a similar antihypertensive effect. The intervention for high-normal blood pressure with telmisartan and indapamide appeared to be feasible and reduced the risk of metabolic syndrome. Telmisartan was more effective, whereas indapamide had better pharmacoeconomic benefits.Hypertension Research advance online publication, 2 October 2014; doi:10.1038/hr.2014.148.
Authors:
Jie Peng; Yingxin Zhao; Hua Zhang; Zhendong Liu; Zhihao Wang; Mengxiong Tang; Ming Zhong; Fanghong Lu; Wei Zhang
Related Documents :
6240454 - The inhomogeneity and appropriateness of the myocardial response to stress.
4030044 - Role of acetyl glyceryl ether phosphorylcholine in blood pressure regulation in rats.
4017264 - The importance of endogenous digoxin-like factors in rats with various forms of experim...
25273554 - Prevention of metabolic disorders with telmisartan and indapamide in a chinese populati...
22051284 - Aortic erosion during negative pressure therapy in a pediatric heart transplant recipient.
8730344 - Calcium channel blockers versus ace inhibitors as antihypertensives in polycystic kidne...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-02
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  -     ISSN:  1348-4214     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-10-2     Completed Date:  -     Revised Date:  2014-10-3    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Zinc and smoking habits in the setting of hypertension in a Spanish populations.
Next Document:  Induction of focal adhesions and motility in Drosophila S2 cells.